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Diabetic hyperglycaemic crisis is a major reason for high-care unit 
admissions,1 with mortality rates of up to 30%.2-9 It is characteristically 
classified as ketoacidotic or hyperosmolar.10 Presentations with the 
combination of ketoacidosis and hyperosmolality are recognised,6,7,11-16 
and have variably been described as ketoacidosis with hyperosmolality 
or hyperosmolar state with ketoacidosis, depending on whether 
ketoacidosis or hyperosmolality was considered dominant.15 
Therapy and outcome of treatment for hyperglycaemic crisis 
is related to the presence of hyperosmolality and ketoacidosis.1 
Hyperosmolality is associated with the use of hypotonic fluids, 
anticoagulation and the more frequent occurrence of vascular 
thrombosis,17 while ketoacidosis may necessitate the use of sodium 
bicarbonate.18
Hyperglycaemic hyperosmolar non-ketoacidosis is associated with 
a higher morbidity and mortality than diabetic ketoacidosis,6,7,19 
which is mainly attributed to hyperosmolality, older age6,7 and the 
more frequent association of hyperosmolar non-ketoacidosis with 
type 2 diabetes.19 Few studies6,7,11,13 have described the clinical and 
laboratory features and outcomes of treatment for hyperosmolar 
diabetic ketoacidosis. A single report from Africa11 included only 8 
cases. 
This study investigated the frequencies, presenting characteristics 
and outcomes of admissions for various types of hyperglycaemic 
crisis at Nelson Mandela Academic Hospital, Walter Sisulu University 
(WSU), Mthatha. The hospital is the referral centre for primary 
and secondary health care facilities in the O R Tambo district of 
the Eastern Cape province of South Africa, which has a population 
of about 1.7 million people.20 Like the rest of the province the 
O R Tambo district has poorly developed health infrastructure 
and a disproportionately high burden of communicable diseases, 
particularly HIV/AIDS, tuberculosis and neurocysticercosis. 
Methods
A retrospective review of hospital records of patients with 
hyperglycaemic crisis admitted to the medical department of Nelson 
Mandela Academic Hospital from 1 January 2008 to 31 December 
2009 was performed. Hyperglycaemic crisis referred to admissions 
in which insulin infusion and intravenous fluid rehydration were 
initiated. Data from the records were socio-demographic information, 
diabetes type, precipitating cause for hyperglycaemic crisis, serum 
biochemical measurements at presentation, duration of admission 
and in-hospital deaths. The study was approved by the Ethics 
Committee of WSU.
Admissions were categorised as follows: (i) non-hyperosmolar 
diabetic ketoacidosis (NHDKA); (ii) hyperosmolar diabetic 
ketoacidosis (HDKA); (iii) hyperosmolar hyperglycaemic state 
(HHS); and (iv) hyperglycaemia (HG). Definitions used were: 
NHDKA – blood glucose >13.9 mmol/l, ketosis, serum bicarbonate 
< 18 mmol/l and calculated effective serum osmolality ≤320 mosmol/
kg; HDKA – blood glucose >13.9 mmol/l, ketosis, serum bicarbonate Corresponding author: N S Levitt (dinky.levitt@uct.ac.za)
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Objectives. To describe the frequencies, presenting characteristics 
(demographic, clinical and biochemical) and outcomes (duration of 
admission and mortality rates) for various types of hyperglycaemic 
crisis.
Methods. Retrospective review of medical records of patients 
with hyperglycaemic crisis admitted to Nelson Mandela Academic 
Hospital, Mthatha, E Cape, from 1 January 2008 to 31 December 
2009. Outcome measures were duration of admission and 
mortality.
Results. Data were available for 269 admissions (response rate 
81.0%), 169 females and 100 males. Admissions for hyperglycaemia 
(HG, N=119), and non-hyperosmolar diabetic ketoacidosis 
(NHDKA, N=97) were more frequent than those for hyperosmolar 
hyperglycaemic state (HHS, N=29) and hyperosmolar diabetic 
ketoacidosis (HDKA, N=24). Duration of admission was similar 
in all groups. Mortality was high in all groups, but was higher in 
patients with HDKA (37.5%, risk ratio (RR) 3.88, 95% confidence 
interval (CI) 1.41 - 10.67, p=0.009), HHS (31.0%, RR 2.91, 95% CI 
1.09 - 7.75, p=0.033) and HG (19.5%, RR 1.56, 95% CI 0.75 - 3.21, 
p=0.236) than in those with NHDKA (13.4%). HDKA (62.5%) 
was associated with new-onset diabetes more often than NHDKA 
(27.8%), HHS (44.8%) or HG (17.6%) (p<0.0001). An altered level 
of consciousness was more frequent in HDKA than NHDKA 
admissions (RR 5.71, 95% CI 1.90 - 17.17, p=0.002). 
Conclusions. Duration of hospital stay was similar across groups. 
Mortality rates were high in all groups. New-onset diabetes, altered 
level of consciousness and mortality were more characteristically 
associated with HDKA than any of the other types of hyperglycaemic 
crisis. Optimal glycaemic control in known diabetic patients will 
reduce rates of hyperglycaemic crisis admissions. 
S Afr Med J 2010; 100: 822-826.
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<18 mmol/l, and calculated effective serum osmolality >320 mosm/
kg; HHS – blood glucose >33.3 mmol/l, serum bicarbonate ≥18 
mmol/l, and calculated effective serum osmolality >320 mosm/
kg; and HG – blood glucose >13.9 mmol/l, serum bicarbonate ≥18 
mmol/l, and calculated effective serum osmolality ≤320 mosm/kg. 
Ketosis referred to at least 1+ ketonuria on dipstick urinalysis or 
trace ketonaemia on qualitative laboratory serum analysis. Acidosis 
and severe acidosis were diagnosed on the basis of serum bicarbonate 
levels of <18 mmol/l and <10 mmol/l, respectively. Ketoacidosis 
referred to ketosis with serum bicarbonate level <18 mmol/l. Effective 
osmolality was calculated as: [2(serum sodium in mmol/l) + plasma 
glucose in mmol/l]. Type of diabetes (type 1 and type 2) was 
based on the diagnosis before the index hyperglycaemic crisis. 
New diabetes referred to patients without a previous diagnosis of 
diabetes. Impaired level of consciousness was defined as a Glasgow 
Coma Scale <15, hypernatraemia as uncorrected serum sodium 
>150 mmol/l, hypokalaemia as serum potassium <3.5 mmol/l, 
hyperkalaemia as serum potassium >5.5 mmol/l, hypochloraemia 
as serum chloride <94 mmol/l, and hyperchloraemia as serum 
chloride >104 mol/l. Precipitating factors for hyperglycaemic crisis 
refer to factors including co-morbidities that are associated with 
deterioration in glycaemic levels.
Treatment consisted of intravenous fluids and insulin administered 
according to standard protocols.10 Blood glucose levels were monitored 
hourly and dipstick urinalysis for ketones done 4-hourly, while serum 
electrolytes, urea and creatinine were measured once daily. Potassium 
replacement as 20 mmol of potassium chloride was added to each 
litre of rehydration fluid, after hyperkalaemia had been excluded. 
Use of anticoagulation in patients with hyperosmolality and sodium 
bicarbonate therapy in severe acidosis was rare. 
Statistical analysis
Data were presented as the median (interquartile range) for continuous 
variables and proportions (%) with (number of admissions) for 
discrete variables. The non-parametric Kruskal-Wallis one-way 
ANOVA was used to compare continuous variables between the 
four types of hyperglycaemic crisis, with post-hoc comparisons of 
mean ranks of all pairs of groups. Proportions between two groups 
were compared using Pearson’s chi-square test. Proportions across 
all groups were compared using Pearson’s chi-square test with a 
Bonferroni adjustment. All tests were two-sided and a p-value <0.05 
was considered significant. Logistic regression models were fitted to 
compare risk of mortality, altered level of consciousness and onset of 
new diabetes between the four types of hyperglycaemic crisis. Risk 
was expressed as risk ratio (RR), using the NHDKA as the baseline 
risk group. Data were captured on a customised MS Excel spread 
sheet and analysed using SPSS version 15 (SPSS, Inc, Chicago, IL, 
USA) and Statistica version 9 (StatSoft, Tulsa, Oklahoma, USA).
Results
There were 764 diabetes-related admissions to the medical wards 
during the study; 332 were for DKA, HHS and HG. Complete data 
on key variables such as age, gender, type of diabetes, blood glucose, 
serum sodium, serum bicarbonate, ketosis and duration of admission 
(Table I) were available for 269 admissions, 169 females and 100 males 
(response rate 81%). They comprised 119 HG (44.2%), 97 NHDKA 
(36.1%), 29 HHS (10.8%) and 24 HDKA (8.9%). Ten patients 
admitted 2 - 7 times accounted for a total of 33 admissions (Table 
II). There were readmissions for NHDKA, HDKA and HG but not 
for HHS. The HHS group included 6 admissions with blood glucose 
levels below 33.3 mmol/l. Seven admissions with blood glucose levels 
below 13.9 mmol/l were observed, 4 for NHDKA, 1 for HDKA and 2 
for HG; this was attributed to initial treatment at the referring health 
facilities, which typically took the form of normal saline infusion and 
10 units intravenous bolus of soluble insulin. The 63 admissions for 
which records were not available had the following diagnoses: DKA 
(N=11), HHS (N=5) and HG (N=47). 
The mean ages in the two DKA groups were similar, and significantly 
lower than in the HHS and HG groups (Table I). No person with HHS 
was younger than 40 years or had type 1 diabetes, in contrast to other 
groups. Females dominated all groups except the HHS group, which 
had a majority of males. 
Precipitating factors were identified in 36.1 - 44.8% of admissions 
across the four groups. The predominant factors were infections 
(N=62), cerebrovascular disease (N=17) and poor drug compliance 
(N=11). Of the 17 cases of cerebrovascular disease, 12 were in the 
HG group, 3 in the HHS group, 2 in the HDKA group and none 
in the NHDKA group. One of the 10 patients who died had type 1 
diabetes and died during her 7th admission. The median durations of 
hospitalisation were comparable in all groups.
The four groups had equally high glycated haemoglobin (HbA1c) 
levels at admission (Table III): 1.6% of NHDKA, 0% of HDKA, 0% 
of HHS and 1.3% of HG patients had an HbA1c <7% at admission. 
Hypernatraemia and hyperchloraemia were more prevalent in the 
HDKA group than in the other groups. Hypochloraemia was the 
dominant serum chloride abnormality in NHDKA. Acidosis was 
documented in all groups. The proportions of admissions with 
severe acidosis were comparably high in both ketoacidotic groups; 97 
(53.6%) in NHDKA versus 24 (54.2%) in HDKA. 
Mortality was high in all groups (Table I), and was significantly 
higher in patients with HDKA (RR 3.88, 95% confidence interval (CI) 
1.41 - 10.67, p=0.009), HHS (RR 2.91, 95% CI 1.09 - 7.75, p=0.033) 
and HG (RR 1.56, 95% CI 0.75 - 3.21, p=0.236) than in those with 
NHDKA (Table IV).
There were similar proportions of patients with type 1, type 2 
and new diabetes in the NHDKA group, while the vast majority of 
HDKA admissions were patients with new diabetes (Table I). Taking 
the NHDKA group as a baseline risk group, patients with HDKA and 
HHS had a significantly higher risk of new diabetes (Table IV).
An altered level of consciousness was commonest in the HDKA 
group, followed by HHS, NHDKA and lastly HG. The rates of altered 
level of consciousness were similarly high in the HDKA and HHS 
groups (p=0.714, but higher in both hyperosmolar groups than 
in the NHDKA and HG groups (p=0.001 for HDKA v. NHDKA, 
p=0.007 for HHS v. NHDKA, and p=0.000 for HDKA v. HG and 
HHS v. HG, respectively). The NHDKA and HG groups had similar 
rates of altered level of consciousness (p=0.146). Similar to the above 
analyses, patients with HDKA and HHS had a significantly higher 
risk of altered level of consciousness.
Discussion 
This study found unacceptably high mortality rates across all groups, 
higher representation of newly diagnosed diabetes in the HDKA 
group than in the other groups, and markedly elevated admission 
HbA1c levels in all groups.
The overall mortality rate of 20.2% (deaths per all admissions) in 
the study, with a range from 13.4% for NHDKA to 37.5% for HDKA, 
is higher than the rates of 2.7 - 7.7% for NHDKA and 0 - 9.6% for 
HDKA from centres6,7,11 that admit patients with hyperglycaemic 
crisis into high-care units. Patients with hyperglycaemic emergencies 
in Jamaica,13 also managed in the medical wards, had lower mortality 
rates than ours (6.7%, 25% and 20.3% for NHDKA, HDKA and HHS, 
respectively), indicating that additional factors contribute to our high 
mortality rates. Although the higher mortality rate for HDKA than 
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NHDKA agrees with other reports,6,7,11,13 the former had a similar 
mortality rate to HHS despite the patients being more than 20 years 
younger. This underscores the need to distinguish between these 
forms of ketoacidosis, as the combination of hyperosmolality and 
ketoacidosis had a worse prognosis than ketoacidosis alone despite 
both ketoacidotic groups being relatively young. A tendency to longer 
duration of admission in HDKA than NHDKA has been reported.11 
We are unable to provide an explanation for our patient groups 
having comparable periods of hospital stay.
Admissions for HDKA, in contrast to NHDKA, were likely to be of 
patients with a new diagnosis of diabetes. Although hyperosmolality 
in HHS is explained by an age-related increase in the renal threshold 
for glucose and reduced sensitivity of the thirst centre, it is not clear 
what the underlying mechanism is in our patients with HDKA, 
who were relatively young (41.7% were aged >40 years, compared 
with 100% for HHS) and had new-onset diabetes. We do not 
know whether they had an elevated renal threshold for glucose 
or an increased thirst threshold. It is also possible that as HDKA 
admissions were mainly of newly diagnosed diabetes subjects, who 
were not aware of their diabetes status, they may have presented 
relatively late or not taken adequate fluids to militate against ongoing 
renal losses (which an informed diabetic patient would have known 
it was necessary to do). This may explain why hypernatraemia and 
an altered level of consciousness were more prevalent in HDKA than 
NHDKA admissions. However, we have no data on the duration of 
symptoms or severity of polydipsia before presentation. Admissions 
for HHS and HG with a serum bicarbonate level below 18 mmol/l 
were as categorised, as ketosis was absent at presentation The factors 
probably contributing to low serum bicarbonate in these ketone-
negative patients include uraemic and lactic acidosis, although lactate 
was not routinely measured in our patients. 
While longitudinal studies,3,21,22 particularly in populations of black 
African ancestry, have shown that most patients with ketoacidosis as 
the first manifestation of diabetes have features of type 2 diabetes, 
we were unable to adequately characterise the newly diagnosed 
diabetic patients with NHDKA or HDKA as having type 1 or type 
2 diabetes. Few patients had information on a family history of 
diabetes, a personal or family history of auto-immune diseases, 
Table I. Demographic characteristics, presenting clinical characteristics and outcomes of various types of 
hyperglycaemic crisis
NHDKA HDKA HHS HG p-value
Age (yrs) 33(24 - 48)‡¶ 24(19 - 44)‡¶ 65(54 - 74)*† 58(39 - 68)*† <0.0001
Age >40 yrs§ 46.4% 41.7% 100% 84.9% <0.0001
Ages of patients with new 
diabetes (yrs)§ 
<0.0001
  <25 11.1% 46.7% 0% 4.8%
  25 - 39 55.6% 26.7% 0% 14.3%
  ≥40 33.3% 26.7% 100% 81%
(27) (15) (29) (21)
Females§ 61.9% 87.5% 41.4% 63.9% 0.007
(97) (24) (29) (119)
Type of diabetes§ 
  Type 1 34% 8.3% 0% 10.1% <0.0001
  Type 2 38.1% 29.2% 55.2% 72.3%
  New diabetes 27.8% 62.5% 44.8% 17.6%
(97) (24) (29) (119)
Precipitating factor present 36.1% 37.5% 44.8% 41.2% 0.80
(97) (24) (29) (119)
Unconsciousness§ 37.3% 77.3% 72.2% 27.6% <0.0001
(75) (22) (18) (76)
Duration of admission (d) 7 (5 - 10) 9 (5 - 12) 6 (4 - 11) 7 (4 - 11) 0.57
(97) (24) (29) (119)
Mortality rate§ 13.4% 37.5% 31% 19.5% 0.02
(97) (24) (29) (118)
 
Data are median (interquartile range) or percentages (number of admissions). Numbers in brackets after the percentages are the number of  admissions with data available for variable of 
interest.
Non-parametric post-hoc tests: *p<0.05 v. NHDKA; †p<0.05 v. HDKA; ‡p<0.05 v. HHS; ¶p<0.05 v. HG; §p<0.05 for χ2 test. χ2 test for categorical variables and Kruskal-Wallis test for 
continuous variables.
NHDKA = non-hyperosmolar diabetic ketoacidosis; HDKA = hyperosmolar diabetic ketoacidosis; HHS = hyperosmolar hyperglycaemic state; HG = hyperglycaemia.
825
ORIGINAL ARTICLES
December 2010, Vol. 100, No. 12  SAMJ
weight, height, waist circumference, presence of acanthosis nigricans 
or C-peptide levels. Laboratory markers of islet auto-immunity were 
not performed as this test was not available. 
The very high HbA1c level at presentation in all groups is notable. 
Although admissions for HDKA were predominantly in persons 
newly diagnosed with diabetes, all 15 admissions for HDKA, 
including 8 in newly diagnosed diabetic patients for whom data on 
HbA1c level were available, had HbA1c levels above 10%. The finding 
that an HbA1c <7% was only noted in 2 of 174 admissions (including 
56 patients with newly diagnosed diabetes) with HbA1c levels 
indicates that hyperglycaemic crisis in our setting is preceded by 
chronic hyperglycaemia regardless of whether the patient is known 
to have diabetes or newly diagnosed. Indeed an elevated HbA1c level 
has been reported to be associated with unprovoked ketoacidosis, and 
the suggested mechanism is glucotoxicity to the beta cell.23 Universal 
screening for diabetes is not recommended, but improving glycaemic 
control in our patients already diagnosed with diabetes will reduce 
the occurrence of hyperglycaemic crisis.
Public health measures to reduce deaths from hyperglycaemic crisis 
are urgently needed. This includes educating the general population 
on diabetes prevention through a healthy lifestyle and highlighting 
its common presenting symptoms. Impediments to achieving good 
glycaemic control in diabetic patients, particularly at referring health 
care facilities, must be addressed as chronic hyperglycaemia preceded 
most admissions for hyperglycaemic crisis. A follow-up to a study 
from Soweto23 reporting high mortality in hyperglycaemic crisis 
described significantly reduced deaths following improved education 
and care of patients, particularly those who were most prone to 
hyperglycaemic decompensation.24 
We plan to review outcomes for hyperglycaemic crisis admissions 
in order to assess the impact of our recently established high-care 
unit and accurately ascertain the type of diabetes in our new-onset 
diabetes patients with hyperglycaemic crisis 
We acknowledge the assistance of the medical wards clerk, Miss Q Duba, 
in the retrieval of patient case records.
References
Table II. Profiles of patients with repeated admissions for hyperglycaemic crisis




1 F 23 1 7 5 times for 
NHDKA and 2 
times for HG
Died at last 
admission
2 F 51 2 3 2 times for HG 




3 F 51 2 2 2 times for HDKA Survived all 
admissions




5 F 69 2 3 3 times for HG Survived all 
admissions
6 M 85 2 5 3 times for HG 
and once each 
















10 F 65 2 2 2 times for HG Survived all 
admissions
NHDKA = non-hyperosmolar diabetic ketoacidosis; HDKA = hyperosmolar diabetic ketoacidosis; HG = hyperglycaemia.
  1.    Van Zyl Smit RE, Burch VC, Willcox PA. The provision of appropriate critical care services in secondary 
level hospitals in South Africa. S Afr Med J 2007;97:270-272.
  2.    Wagner A, Risse A, Brill H, Wienahausen-Wilke V, Rothmann M, Sondern K, et al. Therapy of 
severe diabetic ketoacidosis (zero mortality under very-low-dose insulin application). Diabetes Care 
1999;22:674-677.
  3.    Nyenwe E, Loganathan R, Blum S, Ezuteh D, Erani D, Palace M, et al. Admissions for diabetic 
ketoacidosis in ethnic minority groups in a city hospital. Metabolism 2007;56:172-178.
  4.    Ko SH, Lee WY, Lee JH, Kwon HS, Lee JM, Kim SR, et al. Clinical characteristics of diabetic ketoacidosis 
in Korea over the past two decades. Diabet Med 2005;22:466-469.
  5.    Lee HK, Oh YS, Chung YH, Yoo HJ, Shin SH, Son HY, et al. Epidemiological characteristics of 
ketoacidosis among Korean diabetic patients. Korean Med Sci 1987;2:7-11.
  6.    MacIsaac RJ, Lee LY, Mcneil KJ, Tsalmandris C, Jerums G. Influence of age on the presentation and 
outcome of acidosis and hyperosmolar diabetic emergencies. Intern Med J 2002;32:379-385.
  7.    Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O’Sullivan PS. Hyperosmolarity and acidosis 
in diabetes mellitus; a three-year experience in Rhode Island. J Gen Intern Med 1991;6:495-502.
  8.    Mbugua DK, Otieno CF, Kayima JK, Amayo AA, Mcligeyo SO. Diabetic ketoacidosis: clinical 
presentation and precipitating factors at Kenyatta National Hospital. East Afr Med J 2005;82 (Suppl 
12):S191-S196.
  9.    Jabbar A, Farooqui K, Habib A, Islam N, Haque N, Akhter J. Clinical characteristics and outcomes of 
diabetic ketoacidosis in Pakistani adults with diabetes mellitus. Diabet Med 2004;21:920-923.
10.    American Diabetes Association. Hyperglycaemic crisis in diabetes. Diabetes Care 2004;27(S1):S94-
S102.
11.    Pepper DJ, Burch VC, Levitt NS, Cleary S. Hyperglycaemic emergency admissions to a secondary-level 
hospital – an unnecessary financial burden. S Afr Med J 2007;97:963-967.
12.    Hudson O, Menon S, Kaufmann S. Combined hyperglycaemic hyperosmolar syndrome with diabetic 
ketoacidosis as the presentation of diabetes mellitus type 2 in an adolescent female. EndoTrends 
2008;15:1-5.
13.    Chung ST, Perue GG, Johnson A, Younger N, Hoo CS, Pascoe RW, et al. Predictors of hyperglycaemic 
crisis and their associated mortality in Jamaica. Diabetes Res Clin Pract 2006;73:184-190.
826
ORIGINAL ARTICLES
December 2010, Vol. 100, No. 12  SAMJ
Table IV. Logistic regression analysis of risk of death, new diabetes and altered level of consciousness at presentation 
in various groups of hyperglycaemic crisis 
Group                   Death            New diabetes Altered level of consciousness
RR (95% CI) p-value* RR (95% CI) p-value* RR (95% CI) p-value*
HDKA 3.88 (1.41 - 10.67) 0.009 4.32 (1.69 - 11.04) 0.002 5.71 (1.90 - 17.17) 0.002
HHS 2.91 (1.09 - 7.75) 0.033 2.11 (0.90 - 4.96) 0.088 4.36 (1.40 - 13.55) 0.011
HG 1.56 (0.75 - 3.21) 0.236 0.56 (0.29 - 1.06) 0.075 0.60 (0.30 - 1.20) 0.148
NHDKA 1 1 1
* Wald test, NHDKA = baseline risk group. 
NHDKA = non-hyperosmolar diabetic ketoacidosis; HDKA = hyperosmolar diabetic ketoacidosis; HHS = hyperosmolar hyperglycaemic state; HG = hyperglycaemia.
Table III. Presenting serum biochemical measurements in various types of hyperglycaemic crisis
NHDKA HDKA HHS HG p-value
Blood glucose (mmol/l)§ 31.1 (24.1 - 38)‡ 37.8 (22.4 - 57.1)‡
58.6 (41.2 - 
76.4)*† ¶ 27.1 (18 - 33.8)‡
(97) (24) (29) (119) <0.0001
Blood glucose >33.3 mmol/l§ 34% 50% 79.3% 25.2% <0.0001
(97) (24) (29) (119)
HbA1c (%) 12.7 (10.5 - 15.6) 12.5 (11.6 - 15.8) 13 (11.6 - 15.2) 12.2 (10.4 - 14.6) 0.50
(62) (15) (17) (80)
Hypernatraemia§ 0% 66.7% 20.7% 0% <0.0001
(97) (24) (29) (119)
Hypokalaemia 10.6% 17.4% 20.7% 11.9% 0.47
(94) (23) (29) (118)
Hyperkalaemia§ 22.3% 13% 24.1% 9.3% 0.04
(94) (23) (29) (118)
Hypochloraemia§ 45.4% 8.3% 10.7% 41.5% <0.0001
(97) (24) (28) (118) 
Hyperchloraemia§ 13.4% 83.3% 50% 26.7% <0.0001
(97) (24) (28) (75)
Acidosis§ 100% 100% 31% 9.2% <0.0001
(97) (24) (29) (119)
Data are median (interquartile range) or percentages (number of admissions). Numbers in brackets after the percentages are the number of admissions with data available for variable of 
interest.
Non-parametric post-hoc tests: *p<0.05 v. NHDKA; †p<0.05 v. HDKA; ‡p<0.05 v. HHS; ¶p<0.05 v. HG; §p<0.05 for χ2 test. χ2 test for categorical variables and Kruskal-Wallis test for continuous 
variables.
NHDKA = non-hyperosmolar diabetic ketoacidosis; HDKA = hyperosmolar diabetic ketoacidosis; HHS = hyperosmolar hyperglycaemic state; HG = hyperglycaemia.
14.    Dean H. Acute hyperglcaemic emergencies in children with type 2 diabetes. Paediatr Child Health 
2007;12:43-44.
15.    Levetan BN, Levitt NS, Bonnici F. Hyperglycaemic emergencies are a common problem. S Afr Med J 
1997;87:368-370.
16.    Anumah F, Ohwovoriole A. Serum biochemistry in Nigerians with hyperglycaemic emergencies. Ethn 
Dis 2008;18:26-30.
17.    Small M, Alzard A, Maccuish AC. Diabetic hyperosmolar non-ketotic decompensation. Q J Med 
1988;25:251-257.
18.    Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of 
hyperglycaemic crises in patients with diabetes. Diabetes Care 2001;24:131-153.
19.    Okoro EO, Yusuf M, Salawu HO, Oyejola BA. Outcome of diabetic hyperglycaemic emergencies in a 
Nigerian cohort. Journal of Chinese Clinical Medicine 2007;2:77-82.
20.    2004 Eastern Cape State of the Environment Report. www.environment.gov.za/soer/ecape/files/2004_
ec_soer/chapter_1_intro.pdf (accessed 18 July 2010). 
21.    Mauvais-Jarvis F, Sobongwi E, Porcher R, Riveline J, Kevorkian J, Vaisse C, et al. Ketosis-prone type 2 
diabetes in patients of Sub-Saharan African origin. Diabetes 2004;53:645-653.
22.    Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis. Type 1 vs 
type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999;159:2317-2322.
23.    Buch E, Irwig LM, Huddle KRL, Krige LP, Krut LH, Kuyl JM. Pointers to preventing hyperglycaemic 
emergencies in Soweto. S Afr Med J 1983;64:705-709.
24.    Huddle KR, Gill GV. Reducing acute hyperglycaemic mortality in African diabetic patients. Diabet 
Med 1989;6:64-66.
Accepted 3 August 2010.
